A strain of Streptomyces, No. 314 identified as a Streptomyces lavendulae produced under a novel condition of culture, four new antibiotics, mimosamycin and chlorocarcins A, B, and C. Among the components of chlorocarcin complex, chlorocarcin A was found to be most biologically active.
This antibiotic inhibited the growth of Staphylococcus aureus FDA 209P and Corynebacterium diphtheriae at the concentrations of 0.1 and 0.003 mcg/ml, respectively.
Chlorocarcin A also exhibited antitumor activity on EHRLICH carcinoma, ascitic and solid forms, and mouse leukemia L1210. Mimosamycin proved to be mainly active on Mycobacterium tuberculosis and inactive on the experimental murine tumors.
As described in the preceding papery, the Streptomyces strain No. 314 produced, in addition to streptothricin, four new antibiotics, mimosamycin and chlorocarcins A, B, and C, which were determined by a more sensitive and rational antitumor antibiotic screening procedure. In this paper, identification of the producing strain and biological activities of the antibiotics are described. 
Cultural and Physiological Characteristics
The media used in this study were prepared according to the recommendations in " The Actinomycetes" by WAKSMAN2) and those of the International Streptomyces Project (ISP)3). The growth on yeast extract-malt extract agar was used to inoculate each medium studied. Unless otherwise stated, all cultures were incubated at 27°C for 3 weeks. The cultural characteristics and physiological properties of the strain No. 314 are shown in Tables 1 and 2 . 
n-glucose, L-arabinose, maltose, sucrose, Na-acetate, Na-citrate, Na-succinate +: n-glucose, maltose, sucrose, Naacetate, Na-citrate, Na-succinate 
Discussion
In addition to the production of streptothricin group antibiotics, the strain No. 314 produces chlorocarcins and mimosamycin. To date, a limited number of Streptomycetes which produce old and new types of streptothricin group antibiotics have been reported. They are S. candidus (LL-AB6648)), S. griseochromogenes (SF-7019)), S. hygroscopicus (E-749-C,10) LL-AC54111)), S. microflavus (streptothricin12)), S. lavendulae (akimycin,l3) neothricin,14) R-4H,15) streptothricin,16) yazumycin17)), S. olivoreticuli (BD-12,18) BY-8118)), S. racemochromogenes (racemomycin,l9)) and S. sclerogranulatus (sclerothricin20)).
Among these known species of producers, S. lavendulae and S. racemochromogenes resemble the strain No. 314 most closely. According to the description of S. racemochromogenesl9) and to our taxonomic studies (unpublished data), it seems that S. racemochromogenes is a synonym of or is very closely related to S. lavendulae. As a result of comparative studies of the strain No. 314 and S. lavendulae ISP 5069, we identified the strain No. 314 as Streptomyces lavendulae.
The results reported here also showed that, among these antibiotics, chlorocarcin A is the most bioactive. The antibiotic proved to be active on gram-positive bacteria. The only gramnegative bacteria, which is relatively sensitive to chlorocarcin A was found to be Klebsiella pneumoniae. Chlorocarcin A is also highly active on various types of murine tumors. Our preliminary experiment against L 1210 showed that chlorocarcin A has antitumor activity similar to or somewhat better than azaserine. As reported in the preceding paper, these antibiotics have a relatively low toxicity. Their high biological activity, therefore, seems to warrant further investigations for chemotherapeutic agents.
